本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Apellis Pharmaceuticals Inc.

21.47
+0.74003.57%
盘后21.770.3000+1.40%19:57 EDT
成交量:649.01万
成交额:1.34亿
市值:27.16亿
市盈率:-11.77
高:21.80
开:21.00
低:19.25
收:20.73
52周最高:35.72
52周最低:16.10
股本:1.27亿
流通股本:7,811.99万
量比:1.67
换手率:8.31%
股息:- -
股息率:- -
每股收益(TTM):-1.8245
每股收益(LYR):-1.5970
净资产收益率:14.10%
总资产收益率:5.13%
市净率:6.77
市盈率(LYR):-13.44

数据加载中...

2022/06/02

重要事件披露

8-K - Current report
2022/05/04

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/03/25

重要事件披露

8-K - Current report
2022/03/16

重要事件披露

8-K - Current report
2022/02/28

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/28

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/04

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/20

重要事件披露

8-K - Current report
2022/01/10

重要事件披露

8-K - Current report
2021/12/09

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/12/03

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/18

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/17

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/17

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/02

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/09/09

重要事件披露

8-K - Current report